drugset / Trial / NCT05829109

Fecal Microbiota Transplant for Patients With Chronic Pouchitis

NCT05829109

Phase 0 Recruiting 16 enrolled Maia Kayal
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to assess the safety and efficacy of fecal microbiota transplant (FMT) in the treatment of chronic pouchitis.

Timeline

Start
2024-09-01
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Background Metronidazole Small molecule 250 mg Oral
Background Vancomycin Other / unclassified 125 mg Oral

Indications